Accelerated T2 mapping for characterization of prostate cancer. - Wikidata - wikimedia - TriplyDB

Accelerated T2 mapping for characterization of prostate cancer.

Accelerated T2 mapping for characterization of prostate cancer.

http://www.wikidata.org/entity/Q34810427

about

Rapid and accurate T2 mapping from multi-spin-echo data using Bloch-simulation-based reconstruction.Accelerated and motion-robust in vivo T2 mapping from radially undersampled data using bloch-simulation-based iterative reconstruction Relationship between T2 relaxation and apparent diffusion coefficient in malignant and non-malignant prostate regions and the effect of peripheral zone fractional volume.Characterization of gradient echo signal decays in healthy and cancerous prostate at 3T improves with a Gaussian augmentation of the mono-exponential (GAME) model Computer-aided Detection of Prostate Cancer with MRI: Technology and Applications.Multiparametric prostate MRI: focus on T2-weighted imaging and role in staging of prostate cancer.Acceleration of MR parameter mapping using annihilating filter-based low rank hankel matrix (ALOHA).Prostate cancer discrimination in the peripheral zone with a reduced field-of-view T(2)-mapping MRI sequence Fast 3D T2 -weighted imaging using variable flip angle transition into driven equilibrium (3D T2 -TIDE) balanced SSFP for prostate imaging at 3T.Changes in apparent diffusion coefficient and T2 relaxation during radiotherapy for prostate cancer.Rapid quantitative T2 mapping of the prostate using three-dimensional dual echo steady state MRI at 3T.Performance of a fast and high-resolution multi-echo spin-echo sequence for prostate T2 mapping across multiple systems.A novel alternative to classify tissues from T 1 and T 2 relaxation times for prostate MRI.Rotating frame relaxation imaging of prostate cancer: Repeatability, cancer detection, and Gleason score prediction.

P2860

Q30781192-EE97D6D8-6456-487A-9AEB-0A5B7CF30ECE Q30936700-713B0BEF-AE48-4DC8-BE6B-BE79140AFAF1 Q36793589-C2507EFE-3D99-4AB0-A451-CD3BD1223859 Q37118580-97B008F3-C846-4236-8E60-FFA4E5A4076E Q38822172-3D5371F0-30C9-45FC-BFCE-8EF604AB958C Q38837797-6593589E-4A07-4378-88E5-D105EBD9866C Q40147782-205DE138-CA64-4AB0-9945-A11E53D6895C Q40498085-6456C173-3B1F-4D15-8D03-2B1C23917424 Q44553833-5AC67D02-631B-41F1-A0FF-0F6A1012B43A Q45119553-D1338E4E-69C2-4233-954E-B585672776E7 Q46423474-78A0FCD8-F5EE-48F9-9498-D95426DA5847 Q47964968-D472EF9E-9A06-4D7B-89E7-290D1BE6DD6E Q50650029-3674F7D5-9EC7-4E31-9CD0-6CDEF3A692F2 Q50952968-5FCEECE5-7637-4E93-9B94-2371E7B3DE36

P2860

Accelerated T2 mapping for characterization of prostate cancer.

http://www.wikidata.org/entity/Q34810427

description

2011 nî lūn-bûn

@nan

2011 թուականի Մարտին հրատարակուած գիտական յօդուած

@hyw

2011 թվականի մարտին հրատարակված գիտական հոդված

@hy

2011年の論文

@ja

2011年論文

@yue

2011年論文

@zh-hant

2011年論文

@zh-hk

2011年論文

@zh-mo

2011年論文

@zh-tw

2011年论文

@wuu

name

Accelerated T2 mapping for characterization of prostate cancer.

@ast

Accelerated T2 mapping for characterization of prostate cancer.

@en

Accelerated T2 mapping for characterization of prostate cancer.

@nl

type

label

Accelerated T2 mapping for characterization of prostate cancer.

@ast

Accelerated T2 mapping for characterization of prostate cancer.

@en

Accelerated T2 mapping for characterization of prostate cancer.

@nl

prefLabel

Accelerated T2 mapping for characterization of prostate cancer.

@ast

Accelerated T2 mapping for characterization of prostate cancer.

@en

Accelerated T2 mapping for characterization of prostate cancer.

@nl

P1433

Q34810427-215B7F39-67F8-402C-8A34-8BCA3E441F79

P1476

Q34810427-27F8EF64-C1F1-46FF-82E7-5911AEA9FAE5

P2093

Q34810427-3469912B-D8EF-44B4-972A-BF48C42EB921

Q34810427-4154B307-D093-404E-B959-ACF4BAED2C30

Q34810427-63170F24-F140-4F97-8CDC-5F97E14BC536

Q34810427-70FFCFB4-1C73-49B1-BFD9-5616A130F421

Q34810427-9D65D937-1752-4AEC-8A95-D3F322C90558

Q34810427-A69F4494-2E8C-46EF-85D6-2B88ABEE1F63

Q34810427-B59BCA5A-1F45-438A-AF4A-D3C5AC92B189

Q34810427-E5ADCD50-837C-4E90-8505-4A5FC445EA00

Q34810427-E8300C9B-6928-4529-87D3-D1EE2C8F643E

P2860

Q34810427-190E174C-8079-423A-BF99-B7A078D616B3

Q34810427-4D2C8145-6C97-46EA-AC90-21F8DC9EAC42

Q34810427-60164505-16DD-491C-BD78-290888AD9ECE

Q34810427-61C296C4-CFE4-4644-8002-3420978DEE43

Q34810427-64FAA76E-8F47-41CC-9814-F1E74CCDC2F6

Q34810427-66836748-E923-46D6-9A08-7B527B91EA67

Q34810427-71FE5165-92E8-42A7-A042-04B66D22EE39

Q34810427-75BA6F98-2326-43D9-B7B7-35096E8E9F1A

Q34810427-9D5D145A-A7F4-4E38-83D9-2D39703D67BF

Q34810427-CAE2132E-E016-4C0B-B4DE-DA4F29754D40

P304

Q34810427-4353A3D0-9154-46A5-ABB1-9C625775E3E8

P31

Q34810427-B3C740E7-6F67-4876-BFE3-5184187B72B9

P356

Q34810427-92E9E7F1-CA29-4AD4-9047-D1B6943690FA

P433

Q34810427-BEC04B90-5F44-44B0-965B-B584BDE6B739

P478

Q34810427-B0EA5BD1-A854-4745-8067-85E7E44350EF

P50

Q34810427-DDA752A4-683E-42BE-82F0-ADBEB74D60BD

P577

Q34810427-DA828DB6-FBD8-4A46-8C34-04F368C29D2C

P5875

Q34810427-60772E9C-E845-4C2F-8660-B53267178687

P698

Q34810427-6D82340F-82CB-4163-9468-FD3C1C30A4E0

P932

Q34810427-D6688F0B-2D18-4C94-ABDE-DF75F59068E7

P356

P1433

Magnetic Resonance in Medicine

P1476

Accelerated T2 mapping for characterization of prostate cancer.

@en

P2093

Baris Turkbey

http://www.w3.org/2001/XMLSchema#string

Jochen Kruecker

http://www.w3.org/2001/XMLSchema#string

Julien Sénégas

http://www.w3.org/2001/XMLSchema#string

Marcelino Bernardo

http://www.w3.org/2001/XMLSchema#string

Peter A Pinto

http://www.w3.org/2001/XMLSchema#string

Peter L Choyke

http://www.w3.org/2001/XMLSchema#string

Sheng Xu

http://www.w3.org/2001/XMLSchema#string

Stefanie Remmele

http://www.w3.org/2001/XMLSchema#string

Wei Liu

http://www.w3.org/2001/XMLSchema#string

P2860

Cancer statistics, 2009

Comparison of quantitative T2 mapping and diffusion-weighted imaging in the normal and pathologic prostate.

In vivo quantification of citrate concentration and water T2 relaxation time of the pathologic prostate gland using 1H MRS and MRI.

Prostate cancer: value of multiparametric MR imaging at 3 T for detection--histopathologic correlation

Documenting the location of prostate biopsies with image fusion.

Imaging techniques for prostate cancer: implications for focal therapy

Imaging localized prostate cancer: current approaches and new developments.

Prostate cancer: body-array versus endorectal coil MR imaging at 3 T--comparison of image quality, localization, and staging performance.

Comparison of conventional single echo and multi-echo sequences with a fast spin-echo sequence for quantitative T2 mapping: application to the prostate.

Proton MR T2 maps correlate with the citrate concentration in the prostate.

P304

1400-1406

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1002/MRM.22874

http://www.w3.org/2001/XMLSchema#string

P433

5

http://www.w3.org/2001/XMLSchema#string

P478

65

http://www.w3.org/2001/XMLSchema#string

P50

Bradford J. Wood

P577

2011-03-10T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

50365066

http://www.w3.org/2001/XMLSchema#string

P698

21394778

http://www.w3.org/2001/XMLSchema#string

P932

3079019

http://www.w3.org/2001/XMLSchema#string